Want to join the conversation?
$CELG's sales from multiple myeloma drug Revlimid for 2015 increased by 16.5% from last year. This was primarily due to increased unit sales in both U.S. and international markets in addition to price rises in the U.S. market. Increases in market penetration and treatment duration of patients contributed to the increase in U.S. unit sales.
Looks like $BAC is regaining its lost reputation after the 2008 financial crisis. I hope the stock will flourish under Trump.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!